Osteoporosis Disease Management Demonstration Project (0000-037)

Osteoporosis Clinical Trial

Official title:

Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00139425
• Other study ID #: 0000-037
• Secondary ID: 0372005_048
• Status: Completed
• Phase: N/A
• First received: August 29, 2005
• Last updated: October 9, 2015
• Start date: May 2003
• Est. completion date: December 2004

Study information

• Verified date: October 2015
• Source: Merck Sharp & Dohme Corp.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10000
• Est. completion date: December 2004
• Est. primary completion date: December 2004
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 65 Years to 89 Years

Eligibility

Inclusion Criteria:

• Members of the Henry Ford Health System

Exclusion Criteria:

• Individuals who are not members of the Henry Ford Health System

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Osteoporosis

Intervention

Behavioral:
• Disease Management Assessment

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Merck Sharp & Dohme Corp.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Bone mineral density (BMD) testing rates
Secondary	Osteoporosis medication treatment rates